XPLORE2/PIVOTAL IS AN FDA-APPROVED CLINICAL RESEARCH STUDY ON A NOVEL, RESTORATIVE PULMONARY HEART VALVE

The Xplore2/Pivotal study aims to demonstrate the clinical safety and efficacy of the Xeltis restorative pulmonary heart valve device in patients requiring Right Ventricular Outflow Tract (RVOT) reconstruction due to congenital heart defects (CHD)

The Xplore2/Pivotal trial is actively enrolling patients in centers in the United States, Europe and Asia.